Historical overview of the interleukin-6 family cytokine
Open accessThe DOI matches its Crossref record; 103 of the 105 references it cites were found in a registry or an index.
Abstract
Interleukin-6 (IL-6) has been identified as a 26-kD secreted protein that stimulates B cells to produce antibodies. Later, IL-6 was revealed to have various functions that overlap with other IL-6 family cytokines and use the common IL-6 signal transducer gp130. IL-6 stimulates cells through multiple pathways, using both membrane and soluble IL-6 receptors. As indicated by the expanding market for IL-6 inhibitors, it has become a primary therapeutic target among IL-6 family cytokines. Here, we revisit the discovery of IL-6; discuss insights regarding the roles of this family of cytokines; and highlight recent advances in our understanding of regulation of IL-6 expression.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures
![Figure 1. Receptor composition of IL-6 family cytokines. IL-6 family cytokines use gp130 to transduce their signals through gp130 homodimers or gp130-containing heterodimers. IL-6, IL-11, CNTF, CLCF1, and CLCF1/CLF require binding of their nonsignaling receptor to transduce signals. A new group of members (IL-27, IL-35, and IL-39) are heterodimeric cytokines: IL-27 consists of IL-27/p28 (IL-27α) and EBI3 (also known as IL-27β); in conformity to IL-12 containing IL-12p40 (IL-12α) and IL-12p35 (IL-12β), IL-23 (IL-23p19 [IL-23α] and IL-23p40 [IL-23β]), IL-35 (IL-23p40 and EBI3), and IL-39 (IL-23p19 and EBI3; Hunter, 2005; Ning-Wei, 2010; Wang et al., 2016a). These new members activate heterodimers of gp130. IL-6R exerts its biological effects via three different signaling modes. IL-6R expression is restricted to hepatocytes and several types of immune cells, whereas gp130 is ubiquitously expressed, reflecting the diverse roles of IL-6. In the classical mode of IL-6 signaling, the cytokine interacts with mIL-6R in cells that also express gp130 (Hunter and Jones, 2015). IL-6 also binds soluble IL-6R (sIL-6R), which is shed from cells following cleavage by ADAM metalloprotease 17 (ADAM17), and is also created by alternative mRNA splicing (Lust et al., 1992). The IL-6–sIL-6R complex binds to gp130, forming a dimer that initiates intracellular signaling, a process referred to as trans-signaling. Recently, a third mode of IL-6 signaling was identified: IL-6 trans-presentation (Heink et al., 2017). This mode is specific to dendritic cells, in which the IL-6–mIL-6R complex is presented to gp130 expressed on T cells to prime pathogenic Th17 cells. These alternative modes of IL-6 signaling contribute to multiple cellular processes.](https://figures.cochat.ai/paper-figures/0d0052256f4b4b9dbf5a3cb45efbedda/historical-overview-of-the-interleukin-6-family-cytokine-figure-1.jpg)

Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The increased Tag+ T cell effector responses in sgBaat were also accompanied by an increase in both CD4+ T cells and natural killer cells and elevated proinflammatory cytokines [interleukin-12 (IL-12), tumor necrosis factor (TNF), IFN-γ, IL-15, IL-7] and decreased tumor-promoting cytokines such as IL-6, leukemia inhibitory factor, and IL-11 within the liver microenvironment (Fig. 2D and figs. S3,”
From Bile acid synthesis impedes tumor-specific T cell responses during liver cancer (2025) · cites this paper as [24]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Principles of interleukin (IL)-6-type cytokine signalling and its regulation
HEINRICH, P. C., BEHRMANN, I., HAAN, S., HERMANNS, H. M., MÜLLER-NEWEN, G., & SCHAPER, F. (2003) · Biochemical Journal · doi:10.1042/bj20030407 · Cited by 3,272
IL-6 as a keystone cytokine in health and disease
Hunter, C. A., & Jones, S. A. (2015) · Nature Immunology · doi:10.1038/ni.3153 · Cited by 2,511
Hirano, T., Yasukawa, K., Harada, H., Taga, T., Watanabe, Y., Matsuda, T., Kashiwamura, S.-I., Nakajima, K., Koyama, K., Iwamatsu, A., et al. (1986) · Nature · doi:10.1038/324073a0 · Cited by 2,139
Self-citationKishimoto, T. (1989) · Blood · doi:10.1182/blood.v74.1.1.1 · Cited by 2,069
Self-citationStructural design and molecular evolution of a cytokine receptor superfamily.
Bazan, J. F. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.18.6934 · Cited by 2,069
The inhibitory cytokine IL-35 contributes to regulatory T-cell function
Collison, L. W., Workman, C. J., Kuo, T. T., Boyd, K., Wang, Y., Vignali, K. M., Cross, R., Sehy, D., Blumberg, R. S., & Vignali, D. A. A. (2007) · Nature · doi:10.1038/nature06306 · Cited by 2,066
Gauldie, J., Richards, C., Harnish, D., Lansdorp, P., & Baumann, H. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.20.7251 · Cited by 1,635
Pflanz, S., Timans, J. C., Cheung, J., Rosales, R., Kanzler, H., Gilbert, J., Hibbert, L., Churakova, T., Travis, M., Vaisberg, E., et al. (2002) · Immunity · doi:10.1016/s1074-7613(02)00324-2 · Cited by 1,462
Interleukin-6 triggers the association of its receptor with a possible signal transducer, gp130
Taga, T., Hibi, M., Hirata, Y., Yamasaki, K., Yasukawa, K., Matsuda, T., Hirano, T., & Kishimoto, T. (1989) · Cell · doi:10.1016/0092-8674(89)90438-8 · Cited by 1,396
Self-citation(2012) · The Lancet · doi:10.1016/s0140-6736(12)60110-x · Cited by 1,146
Cited by
Items 201–300 of 389
Xu, R., & Gao, Y. (2025) · BMC Neurology · doi:10.1186/s12883-025-04194-5 · Cited by 5
IL‐6 and Olfactory Dysfunction: Focus on Changes, Effects, and Mechanisms
Song, X.-Y., Mou, Y., Wang, H., Wang, Y., Liu, W.-C., Yang, T., Sun, C.-Y., Ren, C., & Song, X. (2025) · Mediators of Inflammation · doi:10.1155/mi/5891188 · Cited by 6
Cai, K., Xia, R., Xu, M., Chen, W., Cai, W., Liu, X., Guo, T., Jiang, W., Yu, C., Feng, J., et al. (2026) · Journal of Nanobiotechnology · doi:10.1186/s12951-026-04381-7 · Cited by 5
Zheng, Z., Chen, Z., Zhou, Y., Zou, Y., Shi, X., Li, X., Liao, J., Yang, J., Li, X., Dai, J., et al. (2023) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2023.117353 · Cited by 5
Sun, Q., Wang, H., & Liu, H. (2023) · Fish & Shellfish Immunology · doi:10.1016/j.fsi.2023.108949 · Cited by 5
Khanom, M. A. A., Hossen, M. S., Barek, M. A., Ahamed, M. S., Alam, M. S., Bhowmik, K. K., Jafrin, S., Aziz, M. A., & Islam, M. S. (2024) · Health Science Reports · doi:10.1002/hsr2.1875 · Cited by 5
The “Heater” of “Cold” Tumors–Blocking IL‐6
Pu, W., Ma, C., Wang, B., Zhu, W., & Chen, H. (2024) · Advanced Biology · doi:10.1002/adbi.202300587 · Cited by 5
Gomes, B. S., Gonçalves, A. B., Lanza, S. Z., Esquisatto, M. A. M., do Bomfim, F. R. C., & Filho, G. D. J. L. (2024) · Photobiomodulation Photomedicine and Laser Surgery · doi:10.1089/pho.2024.0060 · Cited by 5
Pehlivanlar, E., Çakır, D. A., Sanajou, S., Yalçın, H. T., Baydar, T., Erkekoğlu, P., Avci, H., & Şimşek, R. (2024) · TURKISH JOURNAL OF CHEMISTRY · doi:10.55730/1300-0527.3686 · Cited by 5
Zhao, Z., Chen, T., Liu, Q., Hu, J., Ling, T., Tong, Y., Han, Y., Zhu, Z., Duan, J., Jin, Y. C., et al. (2025) · Journal of Inflammation Research · doi:10.2147/jir.s494191 · Cited by 5
Qin, G., Song, R., Sun, J. J., Dai, J., Wang, W., Meng, F., Wang, D., Liu, Z., Sun, B., & Li, C. (2025) · Drug Design Development and Therapy · doi:10.2147/dddt.s499852 · Cited by 5
Duman, B., Börekçi, Ş., Akdeniz, N., Gazioglu, S. B., Deniz, G., & Gemicioğlu, B. (2021) · Journal of Asthma · doi:10.1080/02770903.2021.1962341 · Cited by 5
Regulatory mechanisms underlying interleukin‐6 expression in murine brown adipocytes
Fu, X., Murakami, M., Hashimoto, O., Matsui, T., & Funaba, M. (2024) · Cell Biochemistry and Function · doi:10.1002/cbf.3915 · Cited by 5
Altered monocyte subpopulations and their association with autism spectrum disorder risk in children
Li, W., Zhang, L., Xu, Y., Li, H., Li, B., Sun, S., Zhang, X., Duan, G., Chen, Y., Zhang, J., et al. (2025) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2025.02.028 · Cited by 4
Pan, X., Xie, J., Zhang, Z., Guo, X., Li, J., Lin, D., Qian, Y., Xu, J., Hu, Y., & Shi, J. (2025) · Virology Journal · doi:10.1186/s12985-025-02803-w · Cited by 4
Fidelis, D. E. D. S., Fernandes, M. S. D. S., Ramos, T. L., Silva, C. B. G., Pereira, A. R., Nóbrega, C. G. D. O., de Souza, V. M. O., Yağın, F. H., Aygün, Y., Lagranha, C. J., et al. (2025) · Frontiers in Physiology · doi:10.3389/fphys.2025.1626477 · Cited by 5
Plasma IL-6 level predict the risk of in-hospital mortality in HIV-associated pneumocystis pneumonia
Xia, H., Song, J., Hu, Y., Li, L., Gao, L., & Ma, P. (2025) · BMC Infectious Diseases · doi:10.1186/s12879-025-12188-4 · Cited by 4
Luo, C., Yu, X. F., Hua, L.-Y., Zeng, M.-Q., Xu, H., Duan, C., Xu, S., Da Yu, S. U. N., Ye, L., & He, D. (2025) · World Journal of Stem Cells · doi:10.4252/wjsc.v17.i11.111162 · Cited by 7
Qi, W. M., Huang, C., Zhang, Y., Zeng, H., Qi, C., Tan, S., Li, W., Tian, P., & Li, Y. (2026) · International Journal of Oncology · doi:10.3892/ijo.2026.5860 · Cited by 5
Blood Cytokine Levels in Patients with Alcohol Dependence during Early Withdrawal Treatment
Hsu, S.-H., Kao, C.-F., Chang, H., Meng, S.-C., Shi, J., & Huang, M. (2023) · Taiwanese Journal of Psychiatry · doi:10.4103/tpsy.tpsy_31_23 · Cited by 4
Evaluating the IL‐6 Family of Cytokines Throughout Equine Gestation
Fedorka, C. E., Scoggin, K. E. S., Ali, H. E., & Troedsson, M. H. T. (2024) · American Journal of Reproductive Immunology · doi:10.1111/aji.13910 · Cited by 4
Gao, B., Liu, H., Zhu, M., Zhang, S., Wang, M., Ruan, Y., & Zheng, Y. (2025) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2025.01.014 · Cited by 4
Progress of ADAM17 in Fibrosis‐Related Diseases
Yan, S., Zhao, Y., Yang, Y., Liu, B., Xu, W., Ma, Z., & Yang, Q. (2025) · Mediators of Inflammation · doi:10.1155/mi/9999723 · Cited by 4
Curcumin induces IL-6 receptor shedding via the ADAM10 proteinase
Murai, T., Masaki, Y., & Yasuhara, K. (2025) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2025.151939 · Cited by 4
Garcia-Canovas, M., López-Jara, A., Gonzalez‐Plaza, A., Parrilla, I., Rodríguez‐Martínez, H., Cuello, C., Martinez, E. A., & Gil, M. A. (2025) · Theriogenology · doi:10.1016/j.theriogenology.2025.117483 · Cited by 4
Kalpachidou, T., Kummer, K. K., Handle, V., Zimmermann, D., Peteinareli, M., Quarta, S., Schiefermeier-Mach, N., Castaldi, L., Heppenstall, P. A., Haberberger, R. V., et al. (2025) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2025.102670 · Cited by 6
Louw, S. J., Mayne, E. S., Jacobson, B. F., & Mayne, A. L. H. (2023) · Cytokine · doi:10.1016/j.cyto.2023.156174 · Cited by 4
Shi, L., Ye, Z., Gu, Q., & Li, Y. (2023) · Cellular and Molecular Biology · doi:10.14715/cmb/2023.69.12.41 · Cited by 4
Li, C., Lian, Y., Lin, Y., & Li, Z. (2024) · Infection and Drug Resistance · doi:10.2147/idr.s433755 · Cited by 4
Pang, L., Zhao, Y., Xu, Y., Gao, C., Wang, C., Yu, X., Wang, F., & He, K. (2024) · Biology · doi:10.3390/biology13090711 · Cited by 4
Katsui, K., Ogata, T., Sugiyama, S., Yoshio, K., Kuroda, M., Yamane, M., Hiraki, T., Kiura, K., Toyooka, S., & Kanazawa, S. (2021) · Cancer Diagnosis & Prognosis · doi:10.21873/cdp.10009 · Cited by 4
Obeagu, E. I., Anierobi, C. C., Eze, G. C., Chukwueze, C. M., Makonyonga, R. D., Amadi, N. M., & Hassan, R. (2022) · Journal of Advances in Medical and Pharmaceutical Sciences · doi:10.9734/jamps/2022/v24i630307 · Cited by 4
Obeagu, E. I., Obeagu, G. U., Cantero, M., Okafor, C. J., Bot, Y. S., Eze, G. C., Amadi, N. M., Jakheng, E. W., & Uwakwe, O. S. (2022) · Asian Journal of Medicine and Health · doi:10.9734/ajmah/2022/v20i1030515 · Cited by 4
Ma, Y., Wang, Y., Yao, Y., Zhang, C., Tang, Q., Zhang, H.-F., & Su, Y.-F. (2023) · European Journal of Trauma and Emergency Surgery · doi:10.1007/s00068-023-02300-1 · Cited by 4
Liu, H.-D., Zhang, Q., Xu, W., & Jin, S. (2024) · World Journal of Gastrointestinal Surgery · doi:10.4240/wjgs.v16.i6.1700 · Cited by 3
García-Alvarez, F., Chueca-Marco, Á., Martínez‐Lostao, L., Aso-Gonzalvo, M., Nonay, R. E., & Albareda, J. (2024) · Injury · doi:10.1016/j.injury.2024.111736 · Cited by 4
Favorable inhibitory effect of clodronate on hepatic steatosis in short bowel syndrome model rats
Tsuruno, Y., Nagano, A., Sugita, K., Onishi, S., Tabata, Y., Kedoin, C., Murakami, M., Yano, K., Kawano, T., Hasuzawa, N., et al. (2024) · Pediatric Surgery International · doi:10.1007/s00383-024-05858-y · Cited by 3
Immune status assessment based on plasma proteomics with meta graph convolutional networks
Zhang, M., Xu, N., Cheng, Q., Ye, J., Wu, S., Liu, H., Zhao, C., Yu, L., & Feng, W. (2025) · BMC Genomics · doi:10.1186/s12864-025-11537-6 · Cited by 3
Li, H., Zhijie-Zhang, Yangyang, Xiaohan-Yu, Jinmao-Li, Cui, H., Li, P., & Chen, B. (2025) · Cardiovascular Therapeutics · doi:10.1155/cdr/5632985 · Cited by 4
He, M., Lv, F., Sun, Y., Liu, Q., Liu, F., Lu, M., Liu, X., Jiang, X. G., Liang, J., & Hua, R. (2025) · BMC Women s Health · doi:10.1186/s12905-025-04113-3 · Cited by 3
Zhong, J., Sun, F., Zhou, M., Fu, K., & Yang, H. (2026) · Animals · doi:10.3390/ani16010153 · Cited by 3
Cytokine multimerization: when more is more and sometimes less
Rudloff, I., Christie, M., Deen, N. S., Ellisdon, A. M., Nold‐Petry, C. A., & Nold, M. F. (2026) · Nature reviews. Immunology · doi:10.1038/s41577-026-01290-6 · Cited by 4
Pang, S. (2024) · American Journal of Translational Research · doi:10.62347/arya8831 · Cited by 3
Beneficial effects of non-invasive physical plasma on human periodontal ligament cells in vitro
Eggers, B., Seher, L., Marciniak, J., Pauck, T., Deschner, J., Eick, S., Stope, M. B., Kramer, F., Küchler, É. C., Kirschneck, C., et al. (2024) · Frontiers in Medicine · doi:10.3389/fmed.2024.1443368 · Cited by 3
Zhou, G., & Li, H. (2022) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2022/7625739 · Cited by 3
RetractedChen, K., Zhang, M., Fan, L., & Wang, Z. (2022) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2022/8823231 · Cited by 4
Kaewbandit, N., Malla, A., Boonyayothin, W., Rattanapisit, K., Phetphoung, T., Pisuttinusart, N., Strasser, R., Saetung, R., Tawinwung, S., & Phoolcharoen, W. (2023) · Scientific Reports · doi:10.1038/s41598-023-39106-5 · Cited by 4
Sun, R., Qu, Z., Ji, C., Yang, X., Zhang, Y., & Zou, X. (2023) · Molecules · doi:10.3390/molecules28155929 · Cited by 3
Chemokine and Cytokine Network in Angiogenesis
Mir, M. A., Ishrat, A., & Shah, M. Z. U. H. (2023) · Springer eBooks · doi:10.1007/978-981-99-4657-0_3 · Cited by 4
Covino, D. A., Farina, I., Catapano, L., Sozzi, S., Spadaro, F., Cecchetti, S., Purificato, C., Gauzzi, M. C., & Fantuzzi, L. (2024) · Journal of Leukocyte Biology · doi:10.1093/jleuko/qiae123 · Cited by 3
Interleukin 6 Receptor Inhibitor Levilimab in the Treatment of Rheumatoid Arthritis
Karateev, D. E., & Лучихина, Е. Л. (2022) · Effective Pharmacotherapy · doi:10.33978/2307-3586-2022-18-18-6-10 · Cited by 3
Distinct Phosphorylation of STAT1 Confers Distinct DNA Binding and Gene-regulatory Properties
Metwally, H., & Kishimoto, T. (2020) · Journal of Cellular Signaling · doi:10.33696/signaling.1.012 · Cited by 2
Self-citationLi, Z., Gan, H., Li, S., Xue, Y., Luo, K., Huang, K., Zhang, Y., Wang, Y., Jiang, L., & Zhang, H. (2024) · Journal of Inflammation Research · doi:10.2147/jir.s476522 · Cited by 2
The role of chemokines and interleukins in acute lymphoblastic leukemia: a systematic review
Štajer, M., Horáček, J. M., Kupsa, T., & Зак, П. (2024) · Journal of Applied Biomedicine · doi:10.32725/jab.2024.024 · Cited by 2
Chen, H., Lin, X., Zhang, N.-N., Shi, Z., Zhang, Y., Du, Q., Kong, L., Sun, D., Wang, R., Mou, Z., et al. (2025) · Journal of Proteome Research · doi:10.1021/acs.jproteome.5c00527 · Cited by 2
The interaction between microbes and cytokines in cancer: unraveling the underlying effects
Li, Y., Zhu, Y., Zhang, F., Huang, C. L., & Wang, Z. (2026) · Journal of Translational Medicine · doi:10.1186/s12967-026-08174-2 · Cited by 3
Simant, K., & Venkataraman, K. (2022) · Current Science · doi:10.18520/cs/v123/i6/745-753 · Cited by 2
Karadağ, Ö., Farisoğulları, B., Yağız, B., Erden, A., ADEMOĞLU, Z., Kimyon, G., Bilge, N. Ş. Y., İçaçan, O. C., Kılıç, L., Coşkun, B. N., et al. (2023) · Clinical and Experimental Rheumatology · doi:10.55563/clinexprheumatol/2h6ma1 · Cited by 3
Endolysosome dysfunction in HAND
Hasler, W. A., Rezagholizadeh, N., & Chen, X. (2024) · Elsevier eBooks · doi:10.1016/b978-0-323-99744-7.00034-1 · Cited by 2
Xu, S.-M., Cui, W., Zhang, X., Song, W., Wang, Y., & Zhao, Y. (2024) · Medicine · doi:10.1097/md.0000000000039014 · Cited by 2
Majer, D., Kujawińska, M., Limanówka, P., & Sędek, Ł. (2024) · Immuno · doi:10.3390/immuno4030018 · Cited by 2
Hösel, K., Chasan, B., Tode, J., Rose‐John, S., Roider, J. B., & Ehlken, C. (2024) · Journal of Ophthalmic Inflammation and Infection · doi:10.1186/s12348-024-00441-x · Cited by 2
Huang, Y., Wang, Y., Wu, H., Wang, Y., Deng, Y., Chang, Y., Su, K., Yang, L., Tao, W., & Liu, W. (2024) · Cellular Signalling · doi:10.1016/j.cellsig.2024.111535 · Cited by 2
Review of interleukin-6 polymorphisms in rheumatoid arthritis: a genetic implications
Alhilali, D. N., Mohammed, S. I., & Gorial, F. I. (2024) · Journal Of Advanced Pharmacy Education And Research · doi:10.51847/bxjuquoela · Cited by 2
Wang, L., Qu, M., Li, L., Mei, W., Zhang, F., Hu, Z., Li, G. Z., Xu, L., & Liang, H. (2025) · Frontiers in Veterinary Science · doi:10.3389/fvets.2025.1529383 · Cited by 2
Liu, L., Ma, C., Ji, J., Gao, R., & Li, D. (2025) · Oncology Letters · doi:10.3892/ol.2025.15006 · Cited by 2
Qing, M., Zhou, Y. J., Peng, J., Shang, Q., Deng, J., Zeng, X. Y., Xu, H. Y., & Chen, Q. (2022) · Journal of Oral Pathology and Medicine · doi:10.1111/jop.13366 · Cited by 2
STAT Signature Dish: Serving Immunity with a Side of Dietary Control
Metwally, H. (2025) · Biomolecules · doi:10.3390/biom15040487 · Cited by 2
Self-citationFrolova, N. F., Tomilina, N. A., Usatiuk, S. S., Аrtyukhina, L. Y., Николаевна, Д. Е., Mayorov, V. V. M., Sysoeva, I. P., Stolyarevich, E. S., Kim, I. G., & Volgina, G. V. (2022) · Infectious diseases News Opinions Training · doi:10.33029/2305-3496-2022-11-1-77-84 · Cited by 1
Biomarkers and prognostic potential of oral fluid for early diagnosis of chronic periodontitis
Зуб, А. А., Gayvoronskaya, T., Sirak, E. S., Grigoryan, V., Лайпанова, Ф. М., Shchetinina, E. E., Remizov, N. O., & Григорьевна, С. А. (2022) · Medical news of the North Caucasus · doi:10.14300/mnnc.2022.17054 · Cited by 1
Xie, D., Zhang, Y., Lan, X., Cai, W., Lin, Y., Li, J., Zou, Y., & Yan, H. (2024) · Pharmacological Research - Modern Chinese Medicine · doi:10.1016/j.prmcm.2024.100427 · Cited by 1
Ye, Y.-J. (2024) · American Journal of Translational Research · doi:10.62347/mdqv6936 · Cited by 1
Ali, D. A. A. K., Mohammed, M. M., & Jassim, N. A. (2024) · Al-Rafidain Journal of Medical Sciences · doi:10.54133/ajms.v6i2.910 · Cited by 1
Lourenço, F. D., Teixeira, J. V. L., de Moura, G. A., Rocha, Y. M., Rodrigues, J. P. V., Oliveira, J. R., Pinheiro, C. V. G., Nicolete, L. D. D. F., & Nicolete, R. (2024) · Current Medicinal Chemistry · doi:10.2174/0109298673306158240620071438 · Cited by 1
Pang, R., Liu, K., Liu, B., & Yang, J. (2025) · FASEB BioAdvances · doi:10.1096/fba.2024-00153 · Cited by 1
Li, J., Han, W.-H., Zhang, M.-Y., Fan, J., Li, G.-D., Li, X., & Chen, X. (2025) · Infection and Drug Resistance · doi:10.2147/idr.s507797 · Cited by 1
Petraglia, L., Iacotucci, P., Ferrillo, L., Cabaro, S., Somma, J., Lacava, F., Amaranto, I., Crucito, S., Perrotti, M., Formisano, P., et al. (2025) · Nutrients · doi:10.3390/nu17071239 · Cited by 1
Oncogenic Ras, Yki and Notch signals converge to confer clone competitiveness through Upd2
Wang, Y., Huang, R., Deng, M., He, J., Deng, M., Ishibashi, T., Yu, C., Zhai, Z., & Yan, Y. (2025) · Journal of genetics and genomics/Journal of Genetics and Genomics · doi:10.1016/j.jgg.2025.04.017 · Cited by 1
Inhibitory effect of Alantolactone against varicella-zoster virus in vitro
Wu, X., Chang, Y., Kong, C., Ding, Z., Pan, D., Lin, P., Wang, S., & Mao, G. (2025) · Virology Journal · doi:10.1186/s12985-025-02759-x · Cited by 1
Cota, C. C., Miranda-Castro, S., Souza-Gomes, A. F., Leite, L. B., Forte, P. M., Monteiro, A. M., Pereira, W. V. C., de Moura, S. S., & Nunes-Silva, A. (2025) · Journal of Clinical Medicine · doi:10.3390/jcm14124170 · Cited by 1
Xu, R., & Gao, Y. (2025) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000546762 · Cited by 1
Hu, C., Liu, L., Xiao, H., Zhao, H., Chen, G., & Xie, Y. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1593770 · Cited by 1
Смирнов, А. В., Dzhukeeva, A. I., Ekova, M., Eduardovich, P. V., Bakulin, D. A., Болохов, Н. С., Pokhlebin, A. A., & Tyurenkov, I. N. (2025) · Journal of Volgograd State Medical University · doi:10.19163/1994-9480-2025-22-2-159-164 · Cited by 1
Su, Z., Wang, J., Yao, C., Chen, X., He, B., Xu, X., Xu, X., & Zheng, Y. (2025) · Acta Biomaterialia · doi:10.1016/j.actbio.2025.08.007 · Cited by 1
Toniolo, A., Genoni, A. P., Maccari, G., Chumakov, K., Basolo, F., Bono, G. G., Mauri, M. F., Molteni, F., Arrondini, L., Bertolasi, L., et al. (2025) · Journal of Neurology · doi:10.1007/s00415-025-13364-x · Cited by 1
Szostek, T., Otto‐Ślusarczyk, D., Dobrowolski, M. A., Wisniewski, M., Roszkowski, P. I., & Szulczyk, D. (2025) · Current Medicinal Chemistry · doi:10.2174/0109298673400295250913044755 · Cited by 1
Leptin’s potential mechanisms in ICU-acquired weakness
Li, M., Yang, L., Li, T., Miao, Y., Yang, J., Chen, S., Ma, X., & Xie, P. (2025) · Lipids in Health and Disease · doi:10.1186/s12944-025-02748-7 · Cited by 2
Zhang, J., Liang, F., Wang, W., Qin, Y., & Hu, X. (2025) · Cancer Cell International · doi:10.1186/s12935-025-04024-1 · Cited by 1
Juárez‐Cedillo, T., Martínez‐Rodríguez, N., Rocha‐Cruz, A., Fragoso, J. M., Robles-Ramírez, R. J., & Juárez‐Cedillo, E. (2025) · BMC Geriatrics · doi:10.1186/s12877-025-06782-z · Cited by 1
The study of the therapeutic effect and preliminary mechanism of EGCG on recurrent aphthous ulcer
You, X., Shi, J., Ren, Z., Wang, L., & Zhao, W. (2025) · Scientific Reports · doi:10.1038/s41598-025-30341-6 · Cited by 1
Martins, A. A., Lima, M. L. S., Vieira, G. H. A., Costa, H. E. S., Leitão, R. F. D. C., Ribeiro, S. B., de Medeiros, C. A. C. X., Silva, D. N. D. A., Suksakulchai, R., Pirih, F. Q. M., et al. (2025) · Scientific Reports · doi:10.1038/s41598-025-30737-4 · Cited by 1
Zhao, Z., Huang, Z., Wang, K., Zhang, H., Ren, Y., & Tong, J. (2025) · PLoS ONE · doi:10.1371/journal.pone.0338443 · Cited by 1
Li, J., Ying, R., Luo, J., Guo, X., & Zhang, M. (2026) · PLoS ONE · doi:10.1371/journal.pone.0340976 · Cited by 1
Ávila, L., Seoane, S., Rodríguez-González, S. P., Gois, M., Arias, M., Martinez-Delgado, D., Gómez‐Lado, N., García‐Caballero, T., Aguiar, P., & Pérez-Fernández, R. (2026) · npj Breast Cancer · doi:10.1038/s41523-026-00929-w · Cited by 1
Dissecting temporal regulation of the TLR4–IL-6 axis using systematic targeted inhibition
Gouveia, G. A., ter Heine, R., Kolkman, M., Arns, A. J., Smeets, R. L., Koenen, H. J. P. M., & de Jonge, M. I. (2026) · Scientific Reports · doi:10.1038/s41598-026-50345-0 · Cited by 1
Feng, D., Wang, N., Hao, Y., Zhou, H., Xiang, Q., Yang, X. H., He, Q. J., & Liao, W. (2026) · Chemical and Biological Technologies in Agriculture · doi:10.1186/s40538-026-00954-8 · Cited by 1
Atlas of human gut-associated lymphoid tissue reveals immunomodulatory interactions of B cells
Pitcher, M. J., Sun, X., Dionisi, C., Montorsi, L., Kottoor, S. H., Siu, J. H. Y., Laddach, R., Nuamah, R. A., Pettigrew, G. J., Ellis, R. J., et al. (2026) · Science Immunology · doi:10.1126/sciimmunol.ady8948 · Cited by 1
Negari, I. P., Khoerunnisa, A. N., Huang, C. M., Marito, S., Gankhuyag, U., Nguyen, M. T. T., Khairullah, A. R., & Septani, C. M. (2026) · Biotechnologia · doi:10.5114/bta/221530 · Cited by 1
Refining therapeutic targeting of interleukin-6 by signalling mode selectivity
Rose‐John, S., Waetzig, G. H., & Schreiber, S. (2026) · Nature Reviews Drug Discovery · doi:10.1038/s41573-026-01536-x · Cited by 3
The Yin and the Yang of STAT1 Downstream of TLR4 Endocytosis: STAT1 beyond Interferon Signaling
Metwally, H., & Kishimoto, T. (2020) · Journal of Cellular Immunology · doi:10.33696/immunology.2.044 · Cited by 1
Self-citation
Metadata
- Authors
- Kang, S., Narazaki, M., Metwally, H., & Kishimoto, T.
- Affiliations
- Immunology Frontier Research Center, The University of Osaka (JP)
- The University of Osaka (JP)
- Corresponding author
- Kishimoto, Tadamitsu
- Venue
- Journal of Experimental Medicine
- Publisher
- Rockefeller University Press
- Published
- 2020-04-08
- Volume
- 217
- Issue
- 5
- ISSN
- 0022-1007 (ISSN-L)
- 1540-9538
- PMC
- PMC7201933
- OpenAlex
- W3014527183
- Cited by
- 360
- References
- 105
- Citations by year
- 2026: 25 · 2025: 96 · 2024: 76 · 2023: 72 · 2022: 49 · 2021: 33 · 2020: 9
- FWCI
- 4.37
- Type
- journal article
- Language
- en
- Update notices
- correction (2020-04-27)
- Open access
- hybrid
- doi.org
- Licence
- Locations
- The Journal of Experimental Medicine (publishedVersion, cc-by-nc-sa)
- PubMed Central (publishedVersion, cc-by-nc-sa)
- PubMed (publishedVersion)
- Funders
- Ministry of Education, Culture, Sports, Science and Technology (17K15722, 17K10002)
- Astellas Foundation for Research on Metabolic Disorders
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Cytokine Signaling Pathways and Interactions
- Health Sciences › Medicine › Rheumatology › Rheumatoid Arthritis Research and Therapies
- Life Sciences › Immunology and Microbiology › Immunology › Psoriasis: Treatment and Pathogenesis
- Keywords
- interleukin-6, IL-6 family cytokines, gp130, IL-6 receptor, IL-6 signaling, IL-6 inhibitors, B cell antibody production
- MeSH terms
- Animals, Humans, Models, Biological, Mutation, Interleukin-6, Receptors, Interleukin-6, MicroRNAs, History, 20th Century, Genetic Pleiotropy
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.